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The airway epithelium is a physical and immunological barrier that protects the pulmonary
system from inhaled environmental insults. Uric acid has been detected in the respiratory
tract and can function as an antioxidant or damage associated molecular pattern. We have
demonstrated that human airway epithelial cells are a source of uric acid. Our hypothesis is
that uric acid production by airway epithelial cells is induced by environmental stimuli associ-
ated with chronic respiratory diseases. We therefore examined how airway epithelial cells
regulate uric acid production.
Materials and methods
Allergen and cigarette smoke mouse models were performed using house dust mite (HDM)
and cigarette smoke exposure, respectively, with outcome measurements of lung uric acid
levels. Primary human airway epithelial cells isolated from clinically diagnosed patients with
asthma and chronic obstructive pulmonary disease (COPD) were grown in submerged cul-
tures and compared to age-matched healthy controls for uric acid release. HBEC-6KT cells,
a human airway epithelial cell line, were grown under submerged monolayer conditions for
mechanistic and gene expression studies.
Results
HDM, but not cigarette smoke exposure, stimulated uric acid production in vivo and in vitro.
Primary human airway epithelial cells from asthma, but not COPD patients, displayed ele-
vated levels of extracellular uric acid in culture. In HBEC-6KT, production of uric acid was
sensitive to the xanthine dehydrogenase (XDH) inhibitor, allopurinol, and the ATP Binding
Cassette C4 (ABCC4) inhibitor, MK-571. Lastly, the pro-inflammatory cytokine combination
of TNF-α and IFN-γ elevated extracellular uric acid levels and XDH gene expression in
HBEC-6KT cells.
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Conclusions
Our results suggest that the active production of uric acid from human airway epithelial cells
may be intrinsically altered in asthma and be further induced by pro-inflammatory cytokines.
Introduction
The airway epithelium is a barrier that protects lung from the external world we live in. Each
day this barrier is exposed to over 10000 litres of air, which variably contains a complex mix of
potentially pathogenic insults including allergens, air pollution, cigarette smoke, viruses, bacte-
ria, and fungi[1–6]. In addition to acting as a physical barrier with tight junctions and mucus
production[7], the airway epithelium is an active player in pulmonary immunity by sensing
the external environment and responding with tailored activity. The airway epithelium senses
the external environment in part through innate immune pattern recognition receptors that
recognize pathogen associated molecular patterns (PAMPs) and damage associated molecular
patterns (DAMPs) [1–6]. Following this sensing, immune mediators are secreted by the airway
epithelium into the extracellular space to induce changes in the local environment, recruit and
activate immune cells, and contribute to repair.
The complementary mechanical barrier and immunological properties of the airway epithe-
lium are important for lung health, with dysregulation in these properties observed in chronic
respiratory diseases including asthma [8–10], chronic obstructive pulmonary disease (COPD)
[11–14], and cystic fibrosis[15–17]. The dysfunction of airway epithelial cells in chronic respi-
ratory disease may be evident under basal resting conditions or under stimulation from ago-
nists in the external environment, and genetic and epigenetic factors may also contribute[18].
Epithelial-derived cytokines and DAMPS that initiate early immune responses to environmen-
tal challenges are frequently dysregulated in asthmatics [19–24]. We have recently demon-
strated that human airway epithelial cells are able to secrete the DAMP, uric acid [25], under
basal and stimulated conditions[26]. The importance of this observation needs further explo-
ration as uric acid has been linked to innate immune responses important in asthma and may
be important in other chronic respiratory diseases[27, 28].
Production of uric acid results from metabolism of purines by xanthine dehydrogenase
(XDH) [29, 30]. Evolutionary pressures in humans have rendered uricase dysfunctional, which
is the enzyme responsible for further metabolism of uric acid into a more hydrophilic allantoin
[31, 32]. The end result is accumulation of uric acid within the plasma (240–350μM) that is
regulated by kidney tubular epithelial cells and urinary excretion[33]. From an evolutionary
perspective elevations in uric acid must carry some net benefit to the host with the DAMP
properties of this molecule offset by equally important biological function(s). A clear counter-
balance to the role of uric acid as a DAMP [25, 34, 35] is the antioxidant properties of this
molecule [36–38]. As an antioxidant, uric acid is capable of scavenging oxygen radicals and
protecting ascorbate from oxidation by forming complexes with iron [36, 37]. The delicate bal-
ance of DAMP and antioxidant functions may be impacted by altered uric acid levels, which
may contribute to chronic diseases [28, 39, 40]. In the respiratory tract, uric acid has been
identified in both the upper and lower airways [41, 42], and is elevated following allergen and
particulate matter exposure [28, 43]. The precise biological mechanism(s) that reconciles the
dichotomy of uric acid DAMP and antioxidant functions remains to be determined, although
a transition from soluble concentrations (anti-oxidant) to insoluble crystals (DAMP) may be
important[35]. For these reasons it is imperative to understand the molecular mechanisms
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that regulate uric acid production and the cellular source(s) of this molecule with complex
functions.
We have previously demonstrated that human airway epithelial cells express XDH protein
and secrete uric acid under basal conditions in vitro[26]. We showed that ATP Binding Cas-
sette Transporter C4 (ABCC4) is expressed in airway epithelial cells and contributes to extra-
cellular uric acid transport[26]. Increased uric acid levels have been demonstrated in mouse
and human lungs following house dust mite (HDM) exposure in vivo [28] and in vitro[26].
The mechanism by which HDM elevates uric acid production are unknown and may involve
increased expression and activity of XDH, altered extracellular transport, cellular damage lead-
ing to release of intracellular contents, or a combination. Of these possibilities, regulation of
XDH activity has been examined most extensively, revealing roles for diverse stimuli including
iron, tumor necrosis factor-alpha (TNF-α), interferon-gamma (IFN-γ), dexamethasone, and
hydrogen peroxide (H2O2)[44–48], all of which are relevant stimuli in chronic respiratory
diseases.
Our overarching hypothesis is that uric acid production by airway epithelial cells can be
induced by environmental exposures associated with chronic respiratory diseases. Using in
vivo, in vitro, and clinical samples, we investigated the regulation of extracellular uric acid pro-
duction by human airway epithelial cells. We first demonstrate that exposure to HDM, but not
cigarette smoke, stimulates uric acid production in vivo and in vitro. We next show that
human airway epithelial cells from asthma, but not COPD patients, have elevated levels of
extracellular uric acid in culture. Extracellular levels of uric acid in airway epithelial cell cul-
tures were sensitive to the XDH inhibitor, allopurinol, and the ABCC4 inhibitor, MK-571.
Lastly, we show that the cytokine combination of TNF-α and IFN-γ elevate extracellular uric
acid levels and XDH gene expression in human airway epithelial cells. Our results suggest that
active production of uric acid from human airway epithelial cells may be intrinsically altered
in asthma and be further induced by pro-inflammatory cytokines.
Materials and methods
Reagents
Freshly generated cigarette smoke extract conditioned media was prepared as previously
described [49, 50]. Cigarette smoke from a University of Kentucky 3R4F cigarette was bubbled
through 4 ml of serum-free medium, followed by filtration through a 0.22 μm filter, and
adjustment with fresh media to an absorbance of 0.15 at 320 nm, to generate a 100% cigarette
smoke extract solution. A 4% solution of cigarette smoke extract was made from the 100%
solution for use in our experiments. Allopurinol, MK-571, dexamethasone, and cycloheximide
were purchased from Cayman Chemical (Ann Arbor, Michigan, USA). Amplex Red uric acid
analysis kits and epidermal growth factor (EGF) were purchased from ThermoFisher (Burling-
ton, Ontario, Canada). Ferric ammonium sulfate and H2O2 were purchased from SigmaAl-
drich (Oakville, Ontario, Canada). Recombinant TNF-α and IFN-γ were purchased from
Peprotech (Dollard des Ormeaux, Quebec, Canada). Bronchial epithelial cell growth media
was purchased from Lonza (Mississauga, Ontario, Canada). Keratinocyte serum free growth
media was purchased from Invitrogen (Burlington, Ontario, Canada).
Human and animal ethics approval
All experiments were approved by the University of British Columbia’s Office of Research Ser-
vices Ethics Committee and The University of Newcastle’s Animal and Human Ethics Com-
mittees. For human sample collection ethics approval and informed consent were obtained.
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In vivo mouse models
HDM exposure was performed with Dermatophagoides pteronyssimus extract (Greer Laborato-
ries, Lenoir, NC) on female BALB/c mice, aged 6–8 weeks, purchased from Jackson Laboratory
(Bar Harbor, ME). Mice were exposed to intranasal saline (35 μL) or HDM (25 μg in 35 μL of
saline) under isoflurane anesthesia as previously described [51, 52]. HDM exposure was
performed daily for 5 days, followed by 2 days rest, and repeated for 4 more days. Outcome
measurements were performed 24h post-final exposure. Animal sacrifice was performed by
terminal bleed via the descending aorta on isoflurane anesthetized animals. The ethics
approval number for this study was A15-0189. Cigarette smoke exposure was performed on
female C57BL/6 mice aged 6–8 weeks, purchased from the Central Animal House, The Uni-
versity of Newcastle, Australia. Mice were exposed to University of Kentucky 3R4F cigarettes
or normal room-air using a custom-designed and purpose-build nose-only smoke system.
Mice received cigarettes twice per day with at least 90 minutes of rest in between, 5 days per
week, for 8 weeks, as previously described[13, 14, 53–56]. Animal sacrifice was performed
by terminal bleed via the descending aorta on isoflurane anesthetized animals. The ethics
approval number for this study was A15-0193. We used the Th1 dominant C57Bl/6 mice in
our cigarette smoke model because this strain demonstrates an enhanced immunopathology
and emphysematous phenotype[57]. We used the Th2 dominant BALB/c mice in our HDM
model because this strain demonstrates an enhanced goblet cell metaplasia and airway dys-
function relative to C57Bl/6 mice in allergen exposure models[58]. For all animal studies,
bronchoalveolar lavage (BAL) was performed on intubated animals with 500μL of sterile PBS,
collected on ice, centrifuged to isolate supernatant, and supernatant archived for downstream
uric acid analysis.
In vitro airway epithelial cell culture models
Primary human airway epithelial cells were isolated from bronchial brushings from healthy
subjects and those with physician diagnosed asthma and COPD based on ATS/ERS guidelines
as previously described [59, 60]. Briefly, bronchial brushes were collected into 5ml of warmed
bronchial epithelial cell growth media in a 15 ml conical tube. The brushes and media were
vortexed for 30 seconds to remove cells from the brush. The brush was then removed and
washed via pipette with the media in the conical tube to remove as many cells as possible. Cells
were then centrifuged (1200 rpm for 7 minutes) for isolation, re-suspended in fresh bronchial
epithelial cell growth media, and plated into 24 well culture dishes with 500μL of media. Sub-
ject characteristics are outlined in Table 1. Primary cells were grown under submerged mono-
layer conditions in bronchial epithelial cell growth media (Lonza—Switzerland).
To complement primary human cell experiments, we used a previously validated minimally
immortalized human airway epithelial cell line (HBEC-6KT) grown under submerged mono-
layer conditions in keratinocyte serum free media with 50ng/ml of bovine pituitary extract and
0.6ng/ml of epidermal growth factor [26, 61–64]. All experiments with primary human airway
epithelial cells and HBEC-6KT were performed at 90–95% confluency.
Gene expression analysis
Total RNA was isolated using Qiagen RNEasy mini kits (Toronto, Ontario, Canada). For
quantitative RT-PCR analysis, cDNA was generated using a high capacity cDNA kit (Thermo-
Fisher—Life Technologies, Burlington, Canada). Quantitative RT-PCR was performed on an
ABI StepOnePlus RT-PCR machine using PowerUP SYBR Green PCR master mix (Thermo-
Fisher—Life Technologies, Burlington, Canada). XDH gene expression was normalized to
GAPDH or PPIA based on our validation of a series of house-keeping genes in HBEC-6KT
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(data not shown) after reviewing suggested housekeeping genes for human lung epithelial cells
[65]. qPCR data is represented as log2 fold change relative to control with statistical analysis
performed on ΔΔCT values from independent biological replicates according to methods
defined by Schmittgen and Livak[66].
The following primer sequences were used:
XDH Forward: 5’-CATGGGGAAGACAACCACAGG-3’,
XDH Reverse 5’-ATGGTCCTGATCCTGGCATCC-3’,
GAPDH Forward: 5’- ACGGGAAGCTTGTCATCAAT-3’,
GAPDH Reverse: 5’-CATCGCCCCACTTGATTTT-3’,
PPIA Forward: 5’- ATGCTGGACCCAACACAAAT-3’
PPIA Reverse: 5’-TCTTTCACTTTGCCAAACACC-3’
Table 1. Clinical subject characteristics.
Subject Code Sex Age GOLD Stage Predicted FEV1 Cigarette (Pack/Year)
Healthy Control Subjects
HC079 F 54 NA 105 0
HC085 M 47 NA 112 0
HC092 M 61 NA 96 0
HC080 M 61 NA 94 0
HC120 M 43 NA 117 0
COPD Subjects
CA158 M 70 3 49 60
CA128 M 65 3 49 80
CA139 M 72 3 43 40
CA122 F 70 3 34 39
CA176 M 78 3 38 66
Subject Code Sex Age GINA Classification Predicted FEV1 Cigarette (Pack/Year)
Healthy Control Subjects
HC066 M 65 NA 92 0
HC074 F 60 NA 116 0
HC082 M 52 NA 81 0
HC088 F 65 NA NA NA
HC089 F 69 NA 86 0
Asthmatic Subjects
AS059 F 55 Severe 79 0
AS053 F 45 Severe 90 0
AS065 F 61 Severe 48 0
AS048 F 49 Severe 61 0
AS070 M 59 Severe 92 0
AS068 F 57 Severe 56 0
AS073 M 40 Severe 25 0
AS076 M 43 Severe 77 0
AS079 F 59 Severe 91 0
AS106 F 72 Moderate 81 0
AS087 F 67 Severe 36 0
AS088 M 47 Severe 46 15
https://doi.org/10.1371/journal.pone.0184260.t001
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Statistical analysis
Experiments were performed for an n 3 independent trials as indicated in figure legends.
One-way ANOVAs were performed with a post-hoc Bonferroni correction for multiple com-
parisons. t-tests were performed where only one comparison was performed. A p-value <0.05
was accepted to be a statistically significant difference between groups. Data were analyzed
using GraphPad Software Version 6.0. Data are expressed as means ± standard deviation (SD).
Data deposition
All raw data used for figures and analysis is deposited in S1 File.
Results
HDM exposure, but not cigarette smoke, induces uric acid production in
vivo and in vitro
We have previously demonstrated that uric acid levels are elevated in BAL from mouse models
of allergic airways disease and may be important in asthma pathogenesis[26]. It remains
unknown if elevations in lung uric acid levels are important in other chronic respiratory dis-
eases including COPD. We therefore examined if cigarette smoke exposure induced uric acid
elevations in vivo and in vitro and compared this to induction by HDM. Using an established
in vivo mouse model of cigarette smoke exposure for 8 weeks, we demonstrate that cigarette
smoke fails to alter BAL uric acid levels (Fig 1A). In contrast, HDM exposure for 2 weeks
increased BAL uric acid levels (Fig 1B, p<0.05). We analyzed BAL cell counts to confirm our
exposures were robust and induced inflammatory responses within the lung. Cigarette smoke
exposure induced an increase in total cells (33.610^5 cigarette smoke vs 6.710^5 control air
—p<0.05) that was primarily associated with an increase in neutrophil (1110^5 cigarette
smoke vs 0.810^5 control air—p<0.05) and macrophages (1810^5 cigarette smoke vs 6.5
control air—p<0.05). HDM exposure induced an increase in total cells (129.210^5 HDM vs
16.510^5 diluent—p<0.05). All cell differentials examined were increased including neutro-
phils (6.010^5 HDM vs 1.410^5 diluent—p<0.05), lymphocytes (9.510^5 HDM vs
1.010^5 diluent—p<0.05), macrophages (53.010^5 HDM vs 14.610^5 diluent—p<0.05),
and eosinophils (60.710^5 HDM vs 3.010^5 diluent—p<0.05).
We next interrogated in vitro model systems with human airway epithelial cells. Similar to
in vivo experiments, cigarette smoke exposure conditioned media failed to induce uric acid
release from HBEC-6KT human airway epithelial cells (Fig 1C). In contrast, HDM (50 μg/ml)
exposure increased uric acid release from HBEC-6KT human airway epithelial cells (Fig 1D,
p<0.05), as we have previously shown[26]. We observed no significant increases in XDH gene
expression following cigarette smoke extract exposure or HDM exposure (data not shown).
Airway epithelial cells from asthmatics, but not COPD subjects, have
elevated basal uric acid production
We next explored if primary human airway epithelial cells from individuals with asthma and
COPD differed in basal release of uric acid relative to age-matched healthy controls. Clinical
subject characteristics are listed in Table 1. We demonstrate that airway epithelial cells from
asthmatics have intrinsically elevated levels of uric acid release relative to healthy controls
(Fig 2A, p<0.05). In contrast, airway epithelial cells isolated from individuals with COPD did
not demonstrate any intrinsic abnormalities in uric acid release relative to healthy controls
(Fig 2B).
Xanthine dehydrogenase and uric acid regulation in human airway epithelial cells
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Airway epithelial cell production and extracellular transport of uric acid is
sensitive to allopurinol and MK-571 pharmacological interventions
XDH is the enzyme responsible for uric acid production [29, 30], while ABCC4 is capable of
transporting uric acid to the extracellular space [26, 33, 67]. To confirm that uric acid produc-
tion and extracellular transport are through conventional pathways we performed mechanistic
experiments with allopurinol to inhibit XDH and MK-571 to inhibit ABCC4. Treatment of
Fig 1. Exposure to HDM but not cigarette smoke induces uric acid production in vivo in mouse lungs and in
vitro in human airway epithelial cells. (A) BAL analysis of uric acid levels in mice 24h following exposure to air or
cigarette smoke (n = 10). (B) BAL analysis of uric acid levels in mice 24h following exposure to PBS or HDM (n = 10).
(C) HBEC-6KT human airway epithelial cell culture supernatant analysis of uric acid levels 24h following exposure to
control (media alone) or cigarette smoke (4% cigarette smoke extract conditioned media) (n = 6). (D) HBEC-6KT
human airway epithelial cell culture supernatant analysis of uric acid levels 24h following exposure to control (PBS) or
HDM (50 μg/ml) (n = 6). Data represent mean +/- SD. Significance is represented by * = p<0.05 relative to control.
https://doi.org/10.1371/journal.pone.0184260.g001
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resting HBEC-6KT human airway epithelial cells with allopurinol (500 μM) or MK-571
(20 μM) for 24h attenuated extracellular levels of uric acid from cultured human airway epithe-
lial cells (Fig 3, p<0.05). To determine if allopurinol and MK-571 have impacts at the tran-
scriptional level on XDH and ABCC4, we determined gene expression in control unstimulated
cells. Allopurinol had no impact on XDH or ABCC4 gene expression. In contrast, MK-571
attenuated XDH gene expression and augmented ABCC4 gene expression (Fig 3B–3C).
Fig 2. Primary airway epithelial cells from asthmatics, but not subjects with COPD, generate elevated extracellular uric acid
levels. (A) Cell culture supernatant analysis of uric acid levels in un-stimulated primary human airway epithelial cells from healthy
age-matched control subjects and asthmatics following 24h of culture. (B) Cell culture supernatant analysis of uric acid levels in un-
stimulated primary human airway epithelial cells from healthy age-matched control subjects and those with COPD following 24h of
culture. Data represent mean +/- SD, n = 5–8. Significance is represented by *p<0.05 relative to healthy controls.
https://doi.org/10.1371/journal.pone.0184260.g002
Fig 3. Extracellular uric acid levels from human airway epithelial cells can be attenuated with the XDH inhibitor, allopurinol,
and the ABCC4 inhibitor, MK-571. (A) Allopurinol (500 μM) and MK-571 (20 μM) treatment for 24h attenuated un-stimulated
production of uric acid from HBEC-6KT, a human airway epithelial cell line derived from a healthy individual. (B) XDH and (C) ABCC4
gene expression in HBEC-6KT cells. Data represent mean +/- SD, n = 3. Significance is represented by * = p<0.05 relative to control.
https://doi.org/10.1371/journal.pone.0184260.g003
Xanthine dehydrogenase and uric acid regulation in human airway epithelial cells
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Extracellular uric acid levels in cultured human airway epithelial cells
following chemical stimulation
Diverse chemical compounds have been used to induce XDH activity in a variety of cell types
[44–48, 68]. We therefore explored whether known chemical inducers of XDH activity were
associated with increased extracellular levels of uric acid in cultures of HBEC-6KT human air-
way epithelial cells. Treatment of HBEC-6KT cells with ferric ammonium sulfate (50μM),
cycloheximide (0.01 μg/ml), H2O2 (100 μM), and dexamethasone (10 μg/ml) for 24h all failed
to increase elevations in extracellular uric acid levels in contrast to the positive control of
HDM (50 μg/ml) (Fig 4).
The inflammatory mediators, TNF-α and IFN-γ, induce uric acid
production and XDH gene expression in human airway epithelial cells
Elevations in uric acid and subsequent formation of crystals are danger signals during early
inflammatory events[35, 69, 70]. However, it is unknown if regulation of uric acid production
Fig 4. Extracellular uric acid levels in cultured human airway epithelial cells are not augmented by
diverse chemical exposures. Treatment of HBEC-6KT human airway epithelial cells with ferric ammonium
sulfate (50 μM), cycloheximide (0.01 μg/ml), H2O2 (100 μM), and dexamethasone (10 μg/ml) for 24h did not
induce elevations in extracellular uric acid levels in contrast to the positive control of HDM (50 μg/ml). Data
represent mean +/- SD, n = 3. Significance is represented by * = p<0.05 relative to control.
https://doi.org/10.1371/journal.pone.0184260.g004
Xanthine dehydrogenase and uric acid regulation in human airway epithelial cells
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occurs during early inflammatory events. To investigate this, we examined whether pro-
inflammatory conditions could stimulate uric acid production in human airway epithelial
cells, using TNF-α (20ng/ml) and IFN-γ (1000U/ml) as positive control stimulus based on pre-
vious reports[46]. The combination of TNF-α (20ng/ml) and IFN-γ (1000U/ml), induced an
increase in the production of uric acid from HBEC-6KT human airway epithelial cells, and
this could be attenuated by the inhibition of XDH with allopurinol (500 μM) (Fig 5A, p<0.05).
Associated with the increase in uric acid production, TNF-α and IFN-γ also induced an
increase in XDH gene expression (Fig 5B, p<0.05). Administration of TNF-α or IFN-γ alone
failed to induce any changes in extracellular uric acid levels or XDH gene expression (data not
shown). IL-6 administration had no impact on extracellular uric acid levels or XDH gene
expression (S1 Fig).
EGF supplementation in cell culture media does not induce XDH gene
expression or elevations in extracellular uric acid production
In vitro experiments with human airway epithelial cells commonly use cell culture media con-
taining EGF at varying concentrations. EGF can upregulate XDH gene expression in L2 rat
lung epithelial cells and may be a confounding variable in our in vitro experimental designs
[71]. We therefore determined if a 24h incubation with a three-log10 dose range of EGF could
influence extracellular uric acid levels and XDH gene expression in HBEC-6KT human airway
epithelial cells and compared this to exposure to the standard 0.6ng/ml concentration we
use throughout our experiments. We failed to observe increases in uric acid production or
increase in XDH gene expression with EGF at concentrations ranging from 0.1ng/ml to
10ng/ml (S2 Fig).
Fig 5. TNF-α and IFN-γ elevate extracellular uric acid levels and XDH gene expression in human airway epithelial cells. (A)
HBEC-6KT human airway epithelial cells were treated with TNF-α (20ng/ml) and IFN-γ (1000U/ml) for 24h followed by analysis of cell
culture supernatant for uric acid levels in the presence or absence of allopurinol (500 μM) (B) XDH gene expression following TNF-α
(20ng/ml) and IFN-γ (1000U/ml) treatment for 24h. Data represent mean +/- SD, n = 3. Significance is represented by * = p<0.05
relative to DMSO/control, % = p<0.05 relative to DMSO/ TNF-α+IFN-γ
https://doi.org/10.1371/journal.pone.0184260.g005
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Discussion
The presence of uric acid in lungs may provide an antioxidant capable of protecting from
inhaled environmental insults while simultaneously functioning as an alarm for the immune
system. We set out to explore how airway epithelial cells regulate extracellular uric acid pro-
duction. We demonstrate that exposure to HDM, but not cigarette smoke, stimulates uric acid
production in vivo and in vitro. We next show that airway epithelial cells from asthma, but not
COPD patients, produce elevated levels of extracellular uric acid in culture under basal condi-
tions. We then show that extracellular uric acid levels from airway epithelial cells are produced
by XDH and transported by ABCC4. Lastly, we demonstrate that the pro-inflammatory cyto-
kine combination of TNF-α and IFN-γ elevate extracellular uric acid levels and XDH gene
expression in human airway epithelial cells. Collectively, our results suggest that active produc-
tion of uric acid from human airway epithelial cells may be intrinsically altered in asthma and
may be further induced by pro-inflammatory cytokines. Precisely how elevated airway uric
acid levels contribute to prevention or development of chronic respiratory diseases requires
further study.
Exposure to allergens and particulate matter are important risk factors for the development
and exacerbation of many chronic respiratory diseases. Airway epithelial cells respond to aller-
gens and particulate matter by secreting a variety of immune mediators[1–5]. Human expo-
sure models with allergens and particulate matter induce uric acid production in asthmatics
and healthy controls, respectively[28, 43], that may be produced in part from airway epithelial
cells[26]. Cigarette smoke is another clinically important risk factor for chronic respiratory
disease. To examine whether cigarette smoke exposure induced uric acid similar to allergen
and particulate matter exposure, we performed in vivo and in vitro cigarette smoke exposure
experiments. We used an established in vivo model of chronic cigarette smoke exposure (5
days per week for 8 weeks) that represents exposure in a pack-a-day human smoker[57]. This
model displays the hallmark disease features of neutrophilia, emphysema-like alveolar enlarge-
ment and changes in lung mechanics [53]. However, we failed to detect elevations in airway
uric acid levels. We explored alternative durations of smoking ranging from 1wk to 12wks and
also failed to see elevations in uric acid at any other timepoint (data not shown). To directly
interrogate whether cigarette smoke exposed airway epithelial cells produced uric acid, we
performed in vitro experiments with cigarette smoke extract conditioned media[49, 50]. Con-
sistent with our in vivo experiments, in vitro exposure to cigarette smoke did not elevate extra-
cellular uric acid levels. The data suggest that airway epithelial cell production of uric acid in
response to environmental exposures is not a generalized phenomenon[26] and does not
occur with cigarette smoke.
Intrinsic abnormalities in airway epithelial cells are observed in chronic respiratory diseases
including asthma, COPD, and CF [8–12, 15–17]. It therefore remained possible that intrinsic
abnormalities that impact uric acid production (i.e. XDH expression and activity) and extra-
cellular transport (i.e. ABCC4 expression and activity) could be present in airway epithelial
cells from specific disease phenotypes. To explore this possibility we collected primary human
airway epithelial cells from asthmatics and subjects with COPD and compared each of these
cohorts to appropriately age-matched healthy controls. We demonstrate intrinsic elevations in
extracellular uric acid from airway epithelial cells from asthmatics, but not from those with
COPD. A limitation of this observational study is that we were unable to perform mechanistic
experiments to explore if the intrinsic abnormalities in cells from asthmatics were dependent
on the function of XDH or ABCC4. To address this possibility, we performed an intervention
with the XDH inhibitor, allopurinol, and the ABCC4 inhibitor, MK-571 in a human airway
epithelial cell line from a healthy individual (HBEC-6KT), demonstrating that these two
Xanthine dehydrogenase and uric acid regulation in human airway epithelial cells
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pathways are important for regulating extracellular levels of uric acid. Future studies using dif-
ferent patient populations (e.g. well-controlled vs un-controlled severe asthmatics[72]) are
required to confirm our findings of intrinsic abnormalities in uric acid production from air-
way epithelial cells isolated from asthmatics. The use of pharmacological inhibitors would
determine the contributions of XDH and ABCC4 activity to this observation in asthmatics.
XDH and ABCC4 have historically been pharmacologically targeted at the protein level
with allopurinol and MK-571, respectively. To determine if allopurinol and MK-571 have
impacts at the transcriptional level on XDH and ABCC4, we determined gene expression in
control unstimulated cells. Our data demonstrates that allopurinol does not regulate XDH or
ABCC4 gene expression, supporting the proposed mechanism of action of allopurinol for
direct inhibition of XDH protein function. In contrast, MK-571 had a surprising impact on
down-regulation of XDH gene expression and up-regulation of ABCC4 gene expression.
These results suggest that the mechanism by which MK-571 inhibits uric acid transport to the
extracellular space is likely to be more complex than originally anticipated[26] and involve
both protein inhibition and alterations of genes in this pathway at the transcriptional level. For
these reasons, caution should be used when interpreting the functional outcomes of MK-571
application as an inhibitor of ABCC4-mediated uric acid transport in human airway epithelial
cells.
XDH expression and activity can be induced by diverse chemical stimuli including ferric
ammonium sulfate, cycloheximide, hydrogen peroxide, and dexamethasone[44–48, 68],
although these chemicals have not been assessed for the responses they induce in human air-
way epithelial cells. Following a 24h incubation period, we did not observe any increase in
extracellular uric acid from human airway epithelial cells under any experimental condition,
despite observing an increase with our positive control of HDM. We observed no changes in
cell morphology that would indicate the occurance of cell death (data not shown) for any of
the experimental conditions. A limitation of our study is the examination of extracellular uric
acid levels as a surrogate for intracellular changes in XDH expression and activity. We decided
to quantify extracellular uric acid since this is consistent with related studies examining this
compartment in human, mouse, and in vitro models [25, 26, 28, 41–43] that have explored the
antioxidant and DAMP activities of uric acid. It remains possible that increased XDH gene
and protein expression occurs in response to each chemical stimuli assessed, with intracellular
uric acid concentrations being elevated without extracellular release.
Previous reports have demonstrated that the pro-inflammatory cytokines TNF-α and IFN-
γ were able to induce XDH activity in a Madin-Darby bovine kidney tubular epithelial cells fol-
lowing 24h incubation[46]. We explored whether this mechanism was conserved in human
airway epithelial cells and showed that exposure to TNF-α and IFN-γ did increase extracellular
uric acid levels and XDH gene expression. Consistent with our experiments in un-stimulated
human airway epithelial cells, our data again implicated XDH and ABCC4 in this biological
process. The implications of pro-inflammatory cytokine induction of uric acid production by
airway epithelial cells may be both beneficial and harmful, due to the antioxidant and DAMP
nature of this molecule. In the context of heightened inflammation and recruitment of inflam-
matory cells, oxidative stress may be elevated and the presence of uric acid could scavenge free
radicals[36–38]. Alternatively, the elevations in uric acid may lead to further recruitment of
inflammatory cells and activation of adaptive immune responses[25, 34, 35]. We suggest that
future studies aimed at reconciling the multiple biological activities of uric acid during inflam-
matory events will need to consider the kinetics of uric acid production, extracellular trans-
port, and concentrations in microenvironments, similar to studies exploring cyclic AMP
compartmentalization and regulation[73]. Furthermore, interrogating how other cytokine
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combinations that are frequently associated with the asthma phenotype (e.g. IL-13, IL-4,
TSLP) may reveal novel mechanisms for regulating XDH expression and uric acid production.
In closing, using in vivo, in vitro, and clinical samples, we explored the overarching hypoth-
esis that uric acid production by airway epithelial cells can be induced by stimuli associated
with chronic respiratory diseases. We demonstrate that exposure to the allergen, HDM,
induces uric acid production from human airway epithelial cells and that asthmatics have an
elevated intrinsic production of uric acid. These findings were not observed in airway epithe-
lial cells collected from individuals with a history of cigarette smoking or with in vitro or in
vivo cigarette smoke exposure models. An elevation in uric acid production induced by TNF-α
and IFN-γ is associated with an increase in XDH gene expression and is sensitive to the XDH
inhibitor, allopurinol, and the ABCC4 inhibitor, MK-571. Collectively, our results suggest that
active production of uric acid from human airway epithelial cells may be intrinsically altered
in asthma and may be further induced by pro-inflammatory cytokines. In the future, a deeper
exploration into production kinetics, extracellular transport, and microenvironments will help
uncover the diverse biological roles of uric acid in lung health and disease.
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